Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

ß2-Agonist therapy may contribute to the air pollution and IL-6-associated risk of developing severe asthma with dual-positive TH2/TH17 cells.

Chiarella SE, Budinger GR, Mutlu GM. ß2-Agonist therapy may contribute to the air pollution and IL-6-associated risk of developing severe asthma with dual-positive TH2/TH17 cells. J Allergy Clin Immunol. 2015 Jan; 135(1):290-1.

View in: PubMed

collapse authors with profiles